Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-α therapy

被引：10
|
作者：
Salvatierra, Juan [1 ]
Magro-Checa, Cesar [1 ]
Rosales-Alexander, Jose L. [1 ]
Raya-Alvarez, Enrique [1 ]
机构：
[1] Hosp Univ San Cecilio, Dept Rheumatol, Granada 18012, Spain
来源：
RHEUMATOLOGY | 2011年 / 50卷 / 07期
关键词：
PATIENT; ADALIMUMAB;
D O I：
10.1093/rheumatology/ker166
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1346 / 1348
页数：3
相关论文
共 50 条
  • [31] Interstitial pneumonitis and anti-tumor necrosis factor-α therapy
    Roos, Jonathan C. P.
    Chilvers, Edwin R.
    Ostor, Andrew J. K.
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 238 - 239
  • [32] Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-α therapy in patients with rheumatoid arthritis
    Braun-Moscovici, Y
    Markovits, D
    Zinder, O
    Schapira, D
    Rozin, A
    Ehrenburg, M
    Dain, L
    Hoffer, E
    Nahir, AM
    Balbir-Gurman, A
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (03) : 497 - 500
  • [33] Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
    Feldmann, M
    Brennan, F
    Paleolog, E
    Taylor, P
    Maini, RN
    [J]. EUROPEAN CYTOKINE NETWORK, 1997, 8 (03) : 297 - 300
  • [34] Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis
    Soubrier, Martin
    Jouanel, Pierre
    Mathieu, Sylvain
    Poujol, David
    Claus, Delphine
    Dubost, Jean Jacques
    Ristori, Jean Michel
    [J]. JOINT BONE SPINE, 2008, 75 (01) : 22 - 24
  • [35] Anti-tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis:: No clear answer
    Symmons, DPM
    Silman, AJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (06): : 1703 - 1706
  • [36] Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs
    Bao-Anh Nguyen-Khoa
    Goehring, Earl L., Jr.
    Alexander, Kimberly A.
    Dong, Wei
    Napalkov, Pavel
    Jones, Judith K.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (02) : 119 - 126
  • [37] Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
    Catrina, AI
    af Klint, E
    Ernestam, S
    Catrina, SB
    Makrygiannakis, D
    Botusan, IR
    Klareskog, L
    Ulfgren, AK
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 76 - 81
  • [38] Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-α antibody therapy
    Sekigawa, I.
    Yanagida, M.
    Iwabuchi, K.
    Kaneda, K.
    Kaneko, H.
    Takasaki, Y.
    Jung, G.
    Sone, S.
    Tanaka, Y.
    Ogawa, H.
    Takamori, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 261 - 267
  • [39] Erratum to: Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Gianluigi Mazzoccoli
    Incoronata Notarsanto
    Gennaro Davide de Pinto
    Mariangela Pia Dagostino
    Angelo De Cata
    Giuseppe D’Alessandro
    Roberto Tarquini
    Gianluigi Vendemiale
    [J]. Internal and Emergency Medicine, 2011, 6 : 97 - 97
  • [40] Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis
    Ulfgren, AK
    Andersson, U
    Engström, M
    Klareskog, L
    Maini, RN
    Taylor, PC
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (11): : 2391 - 2396
12345